Submission date
12/09/2003
Registration date
12/09/2003
Last edited
12/12/2019
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Surgery
Retrospectively registered
? Protocol not yet added
? SAP not yet added
? Results not yet added and study completed for more than 2 years
? Raw data not yet added
Study completed

Plain English Summary

Not provided at time of registration

Study website

Contact information

Type

Scientific

Contact name

Mr J Cooper

ORCID ID

Contact details

MO33
NSPD
Women's and Children's Division
North Staffordshire Hospital (NHS) Trust
Newcastle Road
Stoke-on-Trent
ST4 6QG
United Kingdom
+44 (0)1782 552737
a@b.c

Additional identifiers

EudraCT/CTIS number

IRAS number

ClinicalTrials.gov number

Protocol/serial number

N0158108047

Study information

Scientific title

Prospective randomised controlled trial of the usability and complications of two devices for suprapubic catheterisation in gynaecological surgery (TOSCA)

Acronym

Study hypothesis

To identify the most acceptable method of suprapubic catheterisation after colposuspension.

Ethics approval(s)

Not provided at time of registration

Study design

Randomised controlled trial

Primary study design

Interventional

Secondary study design

Randomised controlled trial

Study setting(s)

Hospital

Study type

Treatment

Patient information sheet

Condition

Surgery: Gynaecological

Intervention

All patients undergoing surgery for stress incontinence and extensive pelvic dissection which requires urinary catheterisation will be eligible to enter. Randomisation will be performed by a telephone link to a computer programme. Catheters will be inserted in theatre under general anaesthetic or spinal, irrespective of allocation. Procedures will be carried out by clinicians who have been trained in the insertion of both types of catheter. Data will be collected by questionnaire (three forms: one for the patient, one for the nursing staff, one for the surgeon[s]).

Intervention type

Device

Pharmaceutical study type(s)

Phase

Not Applicable

Drug/device/biological/vaccine name(s)

Primary outcome measure

The primary endpoint will be patient acceptability.

Secondary outcome measures

The secondary endpoint will be complication rates for each catheter, the ease of performance of catheterisation, including any complications reported by the surgeon, and the ease of management of patients (while on catheter) as reported by the nursing staff.

Overall study start date

01/09/2001

Overall study end date

01/09/2003

Reason abandoned (if study stopped)

Eligibility

Participant inclusion criteria

All patients undergoing surgery for urine incontinence or extensive pelvic surgery requiring catheterisation.

Participant type(s)

Patient

Age group

Not Specified

Sex

Female

Target number of participants

Not provided at time of registration

Participant exclusion criteria

1. Lower abdominal scar
2. Bladder tumour
3. Allergy to natural rubber latex
4. Patient does not wish to participate

Recruitment start date

01/09/2001

Recruitment end date

01/09/2003

Locations

Countries of recruitment

England, United Kingdom

Study participating centre

MO33
Stoke-on-Trent
ST4 6QG
United Kingdom

Sponsor information

Organisation

Department of Health (UK)

Sponsor details

Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom

Sponsor type

Government

Website

http://www.doh.gov.uk

Funders

Funder type

Government

Funder name

North Staffordshire Research and Development Consortium (UK)

Alternative name(s)

Funding Body Type

Funding Body Subtype

Location

Results and Publications

Publication and dissemination plan

Not provided at time of registration

Intention to publish date

Individual participant data (IPD) sharing plan

IPD sharing plan summary

Not provided at time of registration

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?

Additional files

Editorial Notes

12/12/2019: No publications found. All search options exhausted.